CompletedInterventionalNot ApplicableUpdated Jun 1, 2026
Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS) | NCT02529475 | Trialant
TerminatedInterventionalPhase 4Updated Nov 18, 2020
Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)
Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)
ClinicalTrials.gov ID
NCT02529475
Lead Sponsor
University Hospital, GrenobleOTHER
Overall Status
Terminated
Study Type
Interventional
Phase
Phase 4
Enrollment
25Actual
Last Update Posted
Nov 18, 2020Actual
Start Date
Feb 1, 2016Actual
Primary Completion Date
Sep 2020Actual
Completion Date
Sep 2020Actual
Official Title
Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)
Brief Summary
This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in healthy subjects
MR Perfusion Imaging will be assess in both cochlea as well
Primary auditory brain pathways will be evaluated through MR diffusion imaging
Meniere Disease
Gadoteric acid
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Major subjects of over 40 years (mean age of Meniere's disease 40 to 50 years)
Informed consent signed
Medical examination performed prior to participation in research
Patients without history of inner ear disease
Recipient of a French social security scheme
Exclusion Criteria:
Patients minors
Patients on a legal protection regime type guardianship